Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Molecular Analysis of Circulating Biomarkers and…

U.S. Department Of Veterans Affairs·Maryland

Molecular Analysis of Circulating Biomarkers and Biomarkers and Biopsy Specimens Analysis

Closes 8/7/2026$100k – $500kSole Source
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs intends to negotiate a research requirement with the University of Wisconsin Circulating Biomarker Core (CBC) to perform comprehensive molecular analysis of circulating biomarkers and biopsy specimens. The applicable NAICS code is 541715, and the PSC/FSC is AJ12. The authority for this action is FAR 13.106-1(b): Soliciting from a single source. • The research will involve molecular analysis of circulating biomarkers and biopsy specimens. • The University of Wisconsin Circulating Biomarker Core (CBC) is the intended sole source contractor. • Interested persons may provide capability statements to the Contracting Officer via email. • The determination to conduct a competitive procurement based on responses to this notice is solely within the discretion of the Contracting Officer.

Attached files

Contact

Veronica B. Dillard

[email protected]

Key dates

Opened
7/24/2026
Closes
8/7/2026

Last updated

Details

Type
Sole Source
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
36C24526Q0703

Budget estimate

$100,000 – $500,000

The budget for this research contract is not explicitly stated in the document. However, considering that it involves comprehensive molecular analysis of circulating biomarkers and biopsy specimens, the cost could be substantial. A rough estimate for the budget could be in the range of $100,000 to $500,000, considering the complexity and scope of the research. This estimate is based on the assumption that the research will require significant resources, including personnel, equipment, and facilities. The actual budget could be higher or lower, depending on the specifics of the contract and the requirements of the research.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 73%

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

Iowa State University·Iowa

70% match

Blood Spot and Dried Urine Testing

Closes 11/6/2026Opened 10/23/2026

U.S. National Institutes of Health·United States of America

69% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

68% match

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Closes 2/7/2027Opened 12/8/2025

U.S. National Institutes of Health·United States of America

68% match

RNomics Molecular Standards

Closes 2/14/2027Opened 8/5/2026

U.S. National Institutes of Health·United States of America

67% match

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Closes 1/7/2028Opened 10/28/2024

U.S. National Institutes of Health·United States of America

67% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. National Institutes of Health·United States of America

67% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. Department Of Health And Human Services·Maryland

66% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. Department Of Veterans Affairs·Texas

65% match

6550--Blood Bank Reagents

Closes 11/5/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

65% match

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Closes 11/5/2029Opened 2/11/2026

U.S. Department Of Health And Human Services·Maryland

65% match

RNA sequencing and whole genome sequencing services

Closes 11/6/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

65% match

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 7/8/2025

University of Massachusetts·Massachusetts

65% match

UMass Amherst University Health Services - Laboratory and/or Clinical Molecular Analyzer

Closes 11/6/2026Opened 10/5/2026

U.S. Food and Drug Administration·United States of America

64% match

Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics

Rolling / TBD closeOpened 11/20/2024

U.S. National Institutes of Health·United States of America

64% match

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Closes 11/23/2026Opened 5/28/2025

U.S. National Institutes of Health·United States of America

64% match

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Closes 10/8/2027Opened 11/21/2024

U.S. National Institutes of Health·United States of America

63% match

Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases

Closes 1/21/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

63% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

63% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

Michigan Department of Health and Human Services – Bureau of Laboratories·Michigan

63% match

Mayo Medical Laboratories (MML)- Second tier testing for NBS

Closes 11/2/2026Opened 10/26/2026

U.S. National Institutes of Health·United States of America

63% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

63% match

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 7/22/2021

U.S. National Institutes of Health·United States of America

63% match

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024